Saturday, 5 September 2026European Markets

CTP And FIN.ETANG BERRE Have A High Dividend Yield And Return On Equity In The Real Estate Sector.

Loading stream...

(vianews) - ctp (ctpnv.as) is among this list of stock assets with the highest dividend rate and return on equity on the real estate sector.

financial asset price forward dividend yield return on equity
ctp (ctpnv.as) €16.26 3.35% 15.92%
fin.etang berre (berr.pa) €10.40 0.99% 7.08%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. ctp (ctpnv.as)

3.35% forward dividend yield and 15.92% return on equity

ctp n.v., together with its subsidiaries, develops, owns, operates, and leases commercial real estate properties in central, western, and eastern europe. it offers industrial properties for various applications, such as warehousing, manufacturing, research and development, and bespoke property applications. the company also develops city-center office campuses and parks. in addition, it is involved in the solar energy business. the company was founded in 1998 and is headquartered in amsterdam, the netherlands. ctp n.v. operates as a subsidiary of ctp holding b.v.

earnings per share

as for profitability, ctp has a trailing twelve months eps of €2.07.

pe ratio

ctp has a trailing twelve months price to earnings ratio of 7.86. meaning, the purchaser of the share is investing €7.86 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.92%.

volatility

ctp's last week, last month's, and last quarter's current intraday variation average was 0.12%, 0.48%, and 1.03%.

ctp's highest amplitude of average volatility was 0.45% (last week), 1.11% (last month), and 1.03% (last quarter).

moving average

ctp's worth is above its 50-day moving average of €15.52 and way above its 200-day moving average of €14.00.

yearly top and bottom value

ctp's stock is valued at €16.26 at 06:30 est, below its 52-week high of €16.40 and way above its 52-week low of €11.12.

volume

today's last reported volume for ctp is 6481 which is 92.7% below its average volume of 88793.

more news about ctp.

2. fin.etang berre (berr.pa)

0.99% forward dividend yield and 7.08% return on equity

financiere et immobiliere de l'etang de berre et de la mediterranee société anonyme engages in the caravanning, parking and restaurant rental businesses. the company is headquartered in carry-le-rouet, france.

earnings per share

as for profitability, fin.etang berre has a trailing twelve months eps of €6.82.

pe ratio

fin.etang berre has a trailing twelve months price to earnings ratio of 1.52. meaning, the purchaser of the share is investing €1.52 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.08%.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on aug 26, 2013, the estimated forward annual dividend yield is 0.99%.

yearly top and bottom value

fin.etang berre's stock is valued at €10.40 at 06:30 est, under its 52-week high of €11.50 and way higher than its 52-week low of €8.80.

more news about fin.etang berre.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com